A 65-year-old with HFrEF (EF 28%) is euvolemic and on guideline quadruple therapy. Which of the following is indicated for acute symptom relief only a...

Question

A 65-year-old with HFrEF (EF 28%) is euvolemic and on guideline quadruple therapy. Which of the following is indicated for acute symptom relief only and not for mortality reduction?

Accepted Answer

Loop diuretics

Answer

ARNI (sacubitril/valsartan)

Answer

Beta blockers (e.g., metoprolol succinate)

Answer

SGLT2 inhibitors

Answer

MRAs (e.g., spironolactone)

us-abfm MCQ (SBA): HFrEF-Symptom vs Outcome Therapy

A 65-year-old with HFrEF (EF 28%) is euvolemic and on guideline quadruple therapy. Which of the following is indicated for acute symptom relief only and not for mortality reduction?